Cargando…

Non Coding RNAs as Regulators of Wnt/β-Catenin and Hippo Pathways in Arrhythmogenic Cardiomyopathy

Arrhythmogenic cardiomyopathy (ACM) is an inherited cardiomyopathy histologically characterized by the replacement of myocardium by fibrofatty infiltration, cardiomyocyte loss, and inflammation. ACM has been defined as a desmosomal disease because most of the mutations causing the disease are locate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piquer-Gil, Marina, Domenech-Dauder, Sofía, Sepúlveda-Gómez, Marta, Machí-Camacho, Carla, Braza-Boïls, Aitana, Zorio, Esther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599412/ https://www.ncbi.nlm.nih.gov/pubmed/36289882 http://dx.doi.org/10.3390/biomedicines10102619

Ejemplares similares

Facts and Gaps in Exercise Influence on Arrhythmogenic Cardiomyopathy: New Insights From a Meta-Analysis Approach
por: Martínez-Solé, Julia, et al.
Publicado: (2021)

Corrigendum: Facts and Gaps in Exercise Influence on Arrhythmogenic Cardiomyopathy: New Insights From a Meta-Analysis Approach
por: Martínez-Solé, Julia, et al.
Publicado: (2022)

Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy
por: Lorenzon, Alessandra, et al.
Publicado: (2017)

Cadaveric Adipose-Derived Stem Cells for Regenerative Medicine and Research
por: Milián, Lara, et al.
Publicado: (2023)

Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance
por: Igual, Begoña M, et al.
Publicado: (2011)

Change in β‐Catenin Localization Suggests Involvement of the Canonical Wnt Pathway in Boxer Dogs with Arrhythmogenic Right Ventricular Cardiomyopathy
por: Oxford, E.M., et al.
Publicado: (2013)

Arrhythmogenic cardiomyopathy
por: Pilichou, Kalliopi, et al.
Publicado: (2016)

Arrhythmogenic cardiomyopathy with left ventricular involvement versus ischemic heart disease: lessons learned from the family study and the reviewed autopsy of a young male
por: Molina, Pilar, et al.
Publicado: (2019)

Merlin, a regulator of Hippo signaling, regulates Wnt/β-catenin signaling
por: Kim, Soyoung, et al.
Publicado: (2016)

Pregnancy in arrhythmogenic cardiomyopathy
por: Wichter, Thomas, et al.
Publicado: (2021)

Scarring/arrhythmogenic cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2023)

The arrhythmogenic cardiomyopathy-specific coding and non-coding transcriptome in human cardiac stromal cells
por: Rainer, Johannes, et al.
Publicado: (2018)

Dishevelling Wnt and Hippo
por: Kim, Nam Hee, et al.
Publicado: (2018)

Regulation of Hippo, TGFβ/SMAD, Wnt/β-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2021)

Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
por: Alania-Torres, Edgardo, et al.
Publicado: (2021)

Arrhythmogenic right ventricular cardiomyopathy
por: Cho, Yongkeun
Publicado: (2018)

Arrhythmogenic left ventricular cardiomyopathy
por: Mirmomen, Seyedeh Mojdeh, et al.
Publicado: (2020)

Natural History of Arrhythmogenic Cardiomyopathy
por: Mattesi, Giulia, et al.
Publicado: (2020)

Metabolic Signature of Arrhythmogenic Cardiomyopathy
por: Volani, Chiara, et al.
Publicado: (2021)

Arrhythmogenic left ventricular cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2022)

What’s New in Arrhythmogenic Cardiomyopathies
por: Çimen, Tolga, et al.
Publicado: (2022)

Arrhythmogenic Right Ventricular Cardiomyopathy
por: Dolkar, Tsering, et al.
Publicado: (2022)

Cross-talk between Wnt/β-catenin and Hippo signaling pathways: a brief review
por: Kim, Minseong, et al.
Publicado: (2014)

Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation
por: Kim, Wantae, et al.
Publicado: (2017)

miRNAs Regulation and Its Role as Biomarkers in Endometriosis
por: Marí-Alexandre, Josep, et al.
Publicado: (2016)

Decreased Expression of Plakophilin-2 and αT-Catenin in Arrhythmogenic Right Ventricular Cardiomyopathy: Potential Markers for Diagnosis
por: Hung, Pei-Fang, et al.
Publicado: (2022)

Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Indik, Julia H, et al.
Publicado: (2003)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Thiene, Gaetano, et al.
Publicado: (2007)

Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis
por: Stadiotti, Ilaria, et al.
Publicado: (2017)

Exploring digenic inheritance in arrhythmogenic cardiomyopathy
por: König, Eva, et al.
Publicado: (2017)

Genetic Animal Models for Arrhythmogenic Cardiomyopathy
por: Gerull, Brenda, et al.
Publicado: (2020)

Focus on arrhythmogenic right ventricular cardiomyopathy
por: Sinagra, Gianfranco, et al.
Publicado: (2020)

Heart Failure in Patients with Arrhythmogenic Cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2021)

Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy
por: Gerull, Brenda, et al.
Publicado: (2021)

Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy
por: Corrado, Domenico, et al.
Publicado: (2021)

Fibro-fatty remodelling in arrhythmogenic cardiomyopathy
por: Kohela, Arwa, et al.
Publicado: (2022)

The Many Faces of Arrhythmogenic Cardiomyopathy: An Overview
por: Tadros, Hanna J, et al.
Publicado: (2023)

Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator( )
por: Jordà, Paloma, et al.
Publicado: (2022)

KCTD11 inhibits progression of lung cancer by binding to β‐catenin to regulate the activity of the Wnt and Hippo pathways
por: Yang, Man, et al.
Publicado: (2021)

Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching
por: Lüönd, Fabiana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vcqi5rfpe8l4bm93tm2bsh8j6